Robert Bitterman
Net worth: 456 677 $ as of 31/05/2026
Net worth: 456 677 $ as of 31/05/2026
Robert J.
Bitterman was the founder of Cutanea Life Sciences, Inc., founded in 2005, where the title held was Executive Chairman from 2019 to 2022.
Current jobs include Chairman, President & Chief Executive Officer at Phio Pharmaceuticals Corp.
since 2024, and Member at the Dermatology Foundation, Women's Dermatologic Society, and Business Leaders Network.
Former jobs include President & Chief Executive Officer at Fibrocell Science, Inc. from 2004 to 2005, President & Chief Executive Officer at Isolagen Technologies, Inc., President & Chief Executive Officer at Maruho Co., Ltd., and President & General Manager at Dermik Laboratories, Inc. from 1994 to 2004.
Education history includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston University, and a doctorate from New York College of Podiatric Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/02/2026 | 4,11,421 ( 3.54% ) | 456 677 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Chief Executive Officer | - |
Women's Dermatologic Society | Corporate Officer/Principal | - |
Dermatology Foundation | Corporate Officer/Principal | - |
Business Leaders Network | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialises innovative dermatology related products | Chief Executive Officer | 01/03/2019 |
| FIBROCELL SCIENCE, INC. | Chief Executive Officer | 25/04/2005 |
Dermik Laboratories, Inc.
Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures health and skin care products | President | 01/01/2004 |
Isolagen Technologies, Inc.
Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops cellular technology | Chief Executive Officer | - |
Maruho Co., Ltd.
Maruho Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacture, and marketing of pharmaceutical products | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Fibrocell Science, Inc.
Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialises innovative dermatology related products | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isolagen Technologies, Inc.
Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops cellular technology | Commercial Services |
Dermik Laboratories, Inc.
Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures health and skin care products | Consumer Non-Durables |
Dermatology Foundation | |
Maruho Co., Ltd.
Maruho Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacture, and marketing of pharmaceutical products | Health Technology |
Women's Dermatologic Society | |
New York College of Podiatric Medicine
New York College of Podiatric Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Business Leaders Network | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions